[AACR] HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation每Mediated TXNRD1 Stabilization to Suppress Ferroptosis |
|
This post will be closed automatically in 2026-08-27 09:40
Reward50points
|
50
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation每Mediated TXNRD1 Stabilization to Suppress Ferroptosis
20
Lipid Nanoparticle每Encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36污 plus Durvalumab Induces an Immunostimulatory Effect within the Tumor Microenvironment in Patients with Advanced Solid Tumors
30
Abstract 955: LY3200882, a novel, highly selective TGF汕RI small molecule inhibitor
30
FDG-PET每Based Selective Deescalation of Chemoradiation in Human Papillomavirus每Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
30
Abstract P2-13-05: Central nervous system metastases as a site of first recurrence in adjuvant therapy trials of HER2+ early breast cancer (EBC)
